Advamcing Molecular Point-of-Care Testing on the Asia Pacific Region to Improve Disease Detection and Patient Outcome

Medical diagnostic testing at or near the point of care—that is, at the time and place of patient care is the new trending topic in the field of medical laboratory. State-of-the-art molecular point-of-care testing for disease detection empowers physicians with the ability to make early evidence-based treatment decisions. With insights by leading industry analysts, let's look at how advance molecular point-of-care testing in the Asia Pacific region has helped improve disease detection and patient outcome.